Table 5.
Cox proportional hazards model of the association of sulfate clearance with disease outcome in CHF, adjusted for associated clinical parameter separately and in conjunction
| Sulfate Clearance |
||
|---|---|---|
| Model | HR* (95% CI) | P value |
| 1: Crude | 0.38 (0.23–0.63) | <0.001‡ |
| 2: Adjusted for diuretics use | 0.42 (0.25–0.71) | 0.001‡ |
| 3: Adjusted for diuretics use and creatinine clearance | 0.71 (0.35–1.44) | 0.344 |
| 4: Adjusted for diuretics use and 24-h urinary sodium | 0.43 (0.25–0.75) | 0.003‡ |
| 5: Adjusted for diuretics use, creatinine clearance and 24-h urinary sodium | 0.72 (0.35–1.45) | 0.354 |
| 6: Adjusted for creatinine clearance | 0.59 (0.30–1.18) | 0.140 |
| 7: Adjusted for creatinine clearance and 24-h urinary sodium | 0.60 (0.30–1.19) | 0.149 |
| 8: Adjusted for 24-h urinary sodium | 0.39 (0.23–0.67) | 0.001‡ |
HR per SD increase. CHF, chronic heart failure; HR, hazard ratio; CI, confidence interval. ‡Significant P value.